Hub71+ Life Sciences | Abu Dhabi Health Tech Accelerator

Hub71+ Life Sciences is Abu Dhabi’s specialist ecosystem driving innovation across biotechnology, MedTech, and digital health. By uniting policy, capital, corporates, research, and talent partners, the program enables founders to reimagine how the world discovers, develops, and delivers health innovation. This specialist environment brings together researchers, regulators, and investors to advance next-generation healthcare solutions from Abu Dhabi to a global stage.

Financial Incentives and Support

Startups onboarded to the program receive AED 250,000 worth of in-kind incentives in the form of support services.
Participants receive AED 250,000 in cash in exchange for equity through a SAFE note.
High-performing startups committed to Abu Dhabi are eligible for a top-up of up to AED 250,000 in exchange for additional equity upon completion of the one-year program.

Application Timeline and Selection Process

Current Intake: Applications are currently being accepted for Cohort 19.
Deadline: The application deadline is February 1, 2026.
Application Review: Sourcing and selection teams review applications between November 2025 and April 2026, with feedback typically provided within three months.
Selection Rounds: The process includes four stages: initial application review, meetings with the Hub71 team, evaluations by Hub71 partners, and a final selection committee.
Onboarding and Launch: Selected startups begin onboarding in June 2026, with the formal 12-month program starting in September 2026.
Rolling Admissions: Applications submitted after the deadline are automatically considered for the subsequent cohort.

Submission Requirements

Completion of all required fields in the official application form.
A comprehensive pitch deck in PDF format covering the problem, solution, value proposition, business model, competition, market traction, and funds raised.
Detailed information regarding the founding team and specific plans for growth within Hub71 and Abu Dhabi.
A commitment from at least one founder to relocate long-term and build a team out of Abu Dhabi.

Program Structure and Phases

Program Launch (4 weeks): Startups set KPIs and identify key growth areas to establish a foundation in the UAE marketplace.
Market Entry Preparation (4 weeks): Guidance on the UAE corporate environment and investor landscape to prepare for regional entry.
Corporate Partners Introduction: Facilitated networking with key partners to explore collaboration opportunities.
Growth Acceleration (4 weeks): Focused sessions on fundraising, market expansion, and scaling operations.
Fundraising Showcase: A dedicated event to meet venture capitalists, culminating in a public Demo Day.
Ongoing Support: Continuous access to vetted service providers and flexible incentives throughout the program duration.

Ecosystem Benefits

Thriving Ecosystem: Integration into Abu Dhabi’s life sciences sector alongside local and international players.
Curated Community: Access to a specialized network focused on biotechnology, precision medicine, advanced therapies, and biomanufacturing.
Mentorship: Tailored guidance from global experts, healthcare leaders, and experienced founders.
Talent and R&D: Direct access to leading universities, research centers, and laboratory facilities.
Networking: Regular events designed to connect founders with like-minded professionals and industry stakeholders.

Partner Landscape

Founding Partners: Department of Health, Emirates Drug Establishment, and ADIO HELM.
Anchor Partners: Cleveland Clinic Abu Dhabi, Ultrahuman, and Abu Dhabi Early Childhood Authority.
Capital Partners: Global Ventures, Globivest Capital, and Nuwa Capital.
Corporate Partners: Masdar City and New Medical Center.
Talent Partners: NYU Abu Dhabi.